Offerings // Corvus Pharmaceuticals, Inc.

CRVS offering history

Every offering-related filing in Corvus Pharmaceuticals, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 581 filings back to Dec 8, 2014.

Last executed offering

Mar 13, 2026

424B5 — priced deal (shares or notes)

Last registration (announced)

Mar 13, 2026

S-3ASR — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Mar 13, 2026	S-3ASR →	REGISTERED	Automatic shelf registration — effective immediately (large filers)
Mar 13, 2026	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 23, 2026	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 21, 2026	S-3MEF →	REGISTERED	S-3MEF registration — capacity to sell shares, not a sale yet
Jan 20, 2026	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Aug 15, 2024	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Aug 6, 2024	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
May 3, 2024	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 8, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Mar 29, 2023	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Nov 2, 2021	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 12, 2021	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 11, 2021	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Mar 20, 2020	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Mar 19, 2020	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Mar 9, 2020	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Nov 12, 2019	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Mar 9, 2018	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Mar 7, 2018	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 21, 2017	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 20, 2017	424B4 →	EXECUTED	Final prospectus — offering priced (typical for IPOs and marketed share deals)
Jun 9, 2017	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
May 26, 2017	S-3/A →	REGISTERED	S-3/A registration — capacity to sell shares, not a sale yet
Apr 3, 2017	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Mar 24, 2016	424B4 →	EXECUTED	Final prospectus — offering priced (typical for IPOs and marketed share deals)
Mar 22, 2016	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Mar 10, 2016	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Feb 8, 2016	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Jan 4, 2016	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet

CRVS offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full CRVS workspace →

CRVS offering FAQ

When did CRVS last execute an offering?

Per SEC filings, Corvus Pharmaceuticals, Inc.'s most recent priced offering document is a 424B5 filed 2026-03-13. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did CRVS last announce or register an offering?

The most recent registration is a S-3ASR filed 2026-03-13. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.